Table 1 Sample characteristics in patients with unprovoked seizure (n = 168)
EPI (n = 15) | EWML (n = 60) | OWML (n = 93) | ||||
|---|---|---|---|---|---|---|
Characteristics | n | % | N | % | n | % |
Sex | ||||||
Female | 3 | 20.0 | 27 | 45.0 | 50 | 53.8 |
Male | 12 | 80.0 | 33 | 55.0 | 43 | 46.2 |
Seizure recurrence reported* | 9 | 64.3 | 13 | 30.2 | 11 | 18.0 |
Diagnosis of epilepsy | 15 | 100.0 | 57 | 95.0 | 63 | 67.7 |
Antiseizure medication started | 15 | 100.0 | 58 | 96.7 | 70 | 75.3 |
Status epilepticus as first seizure | 4 | 26.7 | 16 | 26.7 | 17 | 18.3 |
Death during study-period | 3 | 20.0 | 20 | 33.3 | 21 | 22.6 |
Neuroimaging | ||||||
MRI | 5 | 33.3 | 44 | 73.3 | 70 | 75.3 |
CT** | 10 | 66.7 | 16 | 26.7 | 23 | 24.7 |
Potentially epileptogenic findings*** | ||||||
Postischemic lesion | 7 | 46.7 | 31 | 51.7 | – | – |
Posthemorrhagic lesion | 5 | 33.3 | 14 | 23.3 | – | – |
Tumor/Metastasis | 3 | 20.0 | 20 | 33.3 | 21 | 22.6 |
Hippocampal sclerosis | 1 | 6.7 | 31 | 51.7 | – | – |
Cortical dysplasia | 0 | 0.0 | 1 | 1.7 | – | – |
Cavernoma | 1 | 6.7 | 0 | 0.0 | – | – |
EEG | ||||||
Epileptiform discharge | 1 | 6.7 | 15 | 25.0 | 25 | 26.9 |
No epileptiform findings | 14 | 93.3 | 44 | 73.3 | 67 | 72.0 |
No EEG | 0 | 0.0 | 1 | 1.7 | 1 | 1.1 |